Disclosure Notices
|
|
Life Pharmacy Limited (LPL) | 3:33 pm, Friday 29 August 2008 | LPL | 0.460 |
 0 |
(+0.00%) |
DISCLOSURE NOTICE
Disclosure of directors' and officers' relevant interests
Section 19T, Securities Markets Act 1988
A Disclosure obligation (tick box to note which disclosure obligation
applies)
- Initial disclosure (complete Parts A, B,
C, D, F, and G of this notice) Ongoing disclosure (complete Parts A, B,
C, E, F, and G of this notice)
B Preliminary
Name Samuel Olukayode Shosanya
Name of issuer Life Pharmacy Limited (LPL)
Name of related body corporate (if applicable) N/A
Position you hold in the issuer General Manager Marketing and Merchandising
Date of this disclosure notice 25 August 2008
C Nature of relevant interest
Name of registered holder(s) of security (as required by regulation 6A(b) or
regulation 7(b)) Samuel Olukayode Shosanya
Class and type of security (as required by regulation 6B or regulation 8)
Ordinary shares
Nature of relevant interest in security (as required by regulation 6A(a) or
regulation 7(a)) Registered holder and beneficial owner
D Date (for initial disclosure)
Date of disclosure obligation (as required by regulation 6C) 20 August 2008
E Transaction (for ongoing disclosure)
Date of last disclosure (as required by regulation 13)
Date(s) of acquisition(s) or disposal(s) (as required by regulation 9)
Number of transactions (as required by regulation 12(2), if applicable)
Nature or type of transaction (as required by regulation 11(1)(a))
Consideration (as required by regulation 10)
Number of securities held prior, set out by class and type (as required by
regulation 8)
Number of securities subject to acquisition or disposal (as required by
regulation 11(1)(b))
F Extent of relevant interest
Number of securities held now, set out by class and type (as required by
regulation 6B or regulation 8) 12,500 ordinary shares
G Signature
Signature (as required by regulation 14)
DISCLOSURE NOTICE
Disclosure of directors' and officers' relevant interests
Section 19T, Securities Markets Act 1988
A Disclosure obligation (tick box to note which disclosure obligation
applies)
Initial disclosure (complete Parts A, B,
C, D, F, and G of this notice) Ongoing disclosure (complete Parts A, B,
C, E, F, and G of this notice)
B Preliminary
Name Craig Robert Wilson
Name of issuer Life Pharmacy Limited (LPL)
Name of related body corporate (if applicable) N/A
Position you hold in the issuer Chief Financial Officer
Date of this disclosure notice 25 August 2008
C Nature of relevant interest
Name of registered holder(s) of security (as required by regulation 6A(b) or
regulation 7(b)) Craig Robert Wilson
Class and type of security (as required by regulation 6B or regulation 8)
Ordinary shares
Nature of relevant interest in security (as required by regulation 6A(a) or
regulation 7(a)) Registered holder and beneficial owner
D Date (for initial disclosure)
Date of disclosure obligation (as required by regulation 6C) 20 August 2008
E Transaction (for ongoing disclosure)
Date of last disclosure (as required by regulation 13)
Date(s) of acquisition(s) or disposal(s) (as required by regulation 9)
Number of transactions (as required by regulation 12(2), if applicable)
Nature or type of transaction (as required by regulation 11(1)(a))
Consideration (as required by regulation 10)
Number of securities held prior, set out by class and type (as required by
regulation 8)
Number of securities subject to acquisition or disposal (as required by
regulation 11(1)(b))
F Extent of relevant interest
Number of securities held now, set out by class and type (as required by
regulation 6B or regulation 8) 12,500 ordinary shares
G Signature
Signature (as required by regulation 14)
DISCLOSURE NOTICE
Disclosure of directors' and officers' relevant interests
Section 19T, Securities Markets Act 1988
A Disclosure obligation (tick box to note which disclosure obligation
applies)
Initial disclosure (complete Parts A, B,
C, D, F, and G of this notice) Ongoing disclosure (complete Parts A, B,
C, E, F, and G of this notice)
B Preliminary
Name Janice Evelyn Jones
Name of issuer Life Pharmacy Limited (LPL)
Name of related body corporate (if applicable) N/A
Position you hold in the issuer General Manager Corporate Relations
Date of this disclosure notice 25 August 2008
C Nature of relevant interest
Name of registered holder(s) of security (as required by regulation 6A(b) or
regulation 7(b)) Janice Evelyn Jones
Class and type of security (as required by regulation 6B or regulation 8)
Ordinary shares
Nature of relevant interest in security (as required by regulation 6A(a) or
regulation 7(a)) Registered holder and beneficial owner
D Date (for initial disclosure)
Date of disclosure obligation (as required by regulation 6C) 20 August 2008
E Transaction (for ongoing disclosure)
Date of last disclosure (as required by regulation 13)
Date(s) of acquisition(s) or disposal(s) (as required by regulation 9)
Number of transactions (as required by regulation 12(2), if applicable)
Nature or type of transaction (as required by regulation 11(1)(a))
Consideration (as required by regulation 10)
Number of securities held prior, set out by class and type (as required by
regulation 8)
Number of securities subject to acquisition or disposal (as required by
regulation 11(1)(b))
F Extent of relevant interest
Number of securities held now, set out by class and type (as required by
regulation 6B or regulation 8) 6,250 ordinary shares
G Signature
Signature (as required by regulation 14)
DISCLOSURE NOTICE
Disclosure of directors' and officers' relevant interests
Section 19T, Securities Markets Act 1988
A Disclosure obligation (tick box to note which disclosure obligation
applies)
? Initial disclosure (complete Parts A, B,
C, D, F, and G of this notice) Ongoing disclosure (complete Parts A, B,
C, E, F, and G of this notice)
B Preliminary
Name Jacqueline Ann Dabrowski
Name of issuer Life Pharmacy Limited (LPL)
Name of related body corporate (if applicable) N/A
Position you hold in the issuer Merchandise Manager Beauty Brands
Date of this disclosure notice 25 August 2008
C Nature of relevant interest
Name of registered holder(s) of security (as required by regulation 6A(b) or
regulation 7(b)) Jacqueline Ann Dabrowski
Class and type of security (as required by regulation 6B or regulation 8)
Ordinary shares
Nature of relevant interest in security (as required by regulation 6A(a) or
regulation 7(a)) Registered holder and beneficial owner
D Date (for initial disclosure)
Date of disclosure obligation (as required by regulation 6C) 20 August 2008
E Transaction (for ongoing disclosure)
Date of last disclosure (as required by regulation 13)
Date(s) of acquisition(s) or disposal(s) (as required by regulation 9)
Number of transactions (as required by regulation 12(2), if applicable)
Nature or type of transaction (as required by regulation 11(1)(a))
Consideration (as required by regulation 10)
Number of securities held prior, set out by class and type (as required by
regulation 8)
Number of securities subject to acquisition or disposal (as required by
regulation 11(1)(b))
F Extent of relevant interest
Number of securities held now, set out by class and type (as required by
regulation 6B or regulation 8) 4,000 ordinary shares
G Signature
Signature (as required by regulation 14)
DISCLOSURE NOTICE
Disclosure of directors' and officers' relevant interests
Section 19T, Securities Markets Act 1988
A Disclosure obligation (tick box to note which disclosure obligation
applies)
Initial disclosure (complete Parts A, B,
C, D, F, and G of this notice) Ongoing disclosure (complete Parts A, B,
C, E, F, and G of this notice)
B Preliminary
Name Wai Yong Seet
Name of issuer Life Pharmacy Limited (LPL)
Name of related body corporate (if applicable) N/A
Position you hold in the issuer Merchandise Manager Health and Personal Care
Date of this disclosure notice 25 August 2008
C Nature of relevant interest
Name of registered holder(s) of security (as required by regulation 6A(b) or
regulation 7(b)) Wai Yong Seet
Class and type of security (as required by regulation 6B or regulation 8)
Ordinary shares
Nature of relevant interest in security (as required by regulation 6A(a) or
regulation 7(a)) Registered holder and beneficial owner
D Date (for initial disclosure)
Date of disclosure obligation (as required by regulation 6C) 20 August 2008
E Transaction (for ongoing disclosure)
Date of last disclosure (as required by regulation 13)
Date(s) of acquisition(s) or disposal(s) (as required by regulation 9)
Number of transactions (as required by regulation 12(2), if applicable)
Nature or type of transaction (as required by regulation 11(1)(a))
Consideration (as required by regulation 10)
Number of securities held prior, set out by class and type (as required by
regulation 8)
Number of securities subject to acquisition or disposal (as required by
regulation 11(1)(b))
F Extent of relevant interest
Number of securities held now, set out by class and type (as required by
regulation 6B or regulation 8) 4,000 ordinary shares
G Signature
Signature (as required by regulation 14)
